CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
2.2. Key findings
2.2.1. Top impacting factors
2.2.2. Top investment pockets

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key Forces Shaping vital organs support systems and medical bionics Market
3.2.1. Moderate bargaining power of suppliers
3.2.2. Low threat of new entrants
3.2.3. Low threat of substitutes
3.2.4. Moderate intensity of rivalry
3.2.5. High bargaining power of buyers
3.3. Pricing Analysis
3.3.1. Pricing Analysis, By Region, 2018 & 2025
3.4. Value Chain Analysis
3.5. Impact of government regulations on global vital organs support systems and medical bionics market
3.6. Clinical Trials
3.7. Industry Pain point analysis
3.8. Case Studies
3.8.1. Case Study 01
3.9. Market dynamics
3.9.1. Drivers
3.9.1.1. Increase in incidence of cardiac disorders and growth in geriatric population
3.9.1.2. Rise in number of patients suffering from chronic diseases
3.9.1.3. Technological advancements
3.9.2. Restraints
3.9.2.1. High cost of treatment
3.9.2.2. Stringent approval process
3.9.3. Opportunities
3.9.3.1. Lucrative opportunities in emerging economies

CHAPTER 4: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE
4.1. Overview
4.2. Market size and forecast
4.3. Vital organs support systems
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by type
4.3.2.1. Artificial Heart
4.3.2.1.1. Market size and forecast
4.3.2.2. Artificial Kidney
4.3.2.2.1. Market size and forecast
4.3.2.3. Artificial Pancreas
4.3.2.3.1. Market size and forecast
4.3.2.4. Artificial Urinary Bladder
4.3.2.4.1. Market size and forecast
4.3.2.5. Artificial Lungs
4.3.2.5.1. Market size and forecast
4.3.2.6. Artificial Liver
4.3.2.6.1. Market size and forecast
4.3.3. Market size and forecast, by region
4.3.4. Market analysis by country
4.4. Medical Bionics
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by type
4.4.2.1. Bionic Eye
4.4.2.1.1. Market size and forecast
4.4.2.2. Ear Bionics
4.4.2.2.1. Market size and forecast, by type
4.4.2.2.1.1.1. Cochlear Implants
4.4.2.2.1.1.1.1 Market size and forecast
4.4.2.2.1.1.2. Bone Anchored Hearing Systems
4.4.2.2.1.1.2.1. Market size and forecast
4.4.2.2.1.1.3. Auditory Brainstem Implants
4.4.2.2.1.1.3.1 Market size and forecast
4.4.2.3. Orthopedic Bionics
4.4.2.3.1. Market size and forecast, by type
4.4.2.3.1.1.1. Upper Limb
4.4.2.3.1.1.2. Market size and forecast
4.4.2.3.1.1.3. Lower Limb
4.4.2.3.1.1.4. Market size and forecast, by type
4.4.2.3.1.1.4.1. Bionic Knee
4.4.2.3.1.1.4.1.1. Market size and forecast
4.4.2.3.1.1.4.2. Bionic Feet
4.4.2.3.1.1.4.2.1. Market size and forecast
4.4.2.3.1.1.5. Exoskeleton
4.4.2.3.1.1.6. Market size and forecast
4.4.2.3.1.1.7. Electrical Bone Growth Stimulators
4.4.2.3.1.1.8. Market size and forecast, by type
4.4.2.3.1.1.8.1. Invasive Bone Growth Stimulators
4.4.2.3.1.1.8.1.1. Market size and forecast
4.4.2.3.1.1.8.2. Non-Invasive Bone Growth Stimulators
4.4.2.3.1.1.8.2.1. Market size and forecast
4.4.2.4. Cardiac Bionics
4.4.2.4.1. Market size and forecast, by type
4.4.2.4.1.1.1. Pacemaker
4.4.2.4.1.1.1.1 Market size and forecast, by type
4.4.2.4.1.1.2. Implantable Pacemaker
4.4.2.4.1.1.2.1. Market size and forecast
4.4.2.4.1.1.3. External pacemaker
4.4.2.4.1.1.3.1 Market size and forecast
4.4.2.4.1.1.3. Ventricular Assist Devices (VADs)
4.4.2.4.1.1.4. Market size and forecast, by type
4.4.2.4.1.1.4.1. Left Ventricular Assist Device (LVAD)
4.4.2.4.1.1.4.1.1. Market size and forecast
4.4.2.4.1.1.4.2. Right Ventricular Assist Device (RVAD)
4.4.2.4.1.1.4.2.1. Market size and forecast
4.4.2.4.1.1.4.3. Biventricular Assist Device (BIVAD)
4.4.2.4.1.1.4.3.1. Market size and forecast
4.4.2.4.1.1.5. Artificial Heart Valves
4.4.2.4.1.1.6. Market size and forecast, by type
4.4.2.4.1.1.6.1. Mechanical Heart Valves
4.4.2.4.1.1.6.1.1. Market size and forecast
4.4.2.4.1.1.6.2. Tissue Heart Valves
4.4.2.4.1.1.6.2.1. Market size and forecast
4.4.2.5. Neural Bionics
4.4.2.5.1. Market size and forecast, by type
4.4.2.5.1.1. Internal Neurostimulators
4.4.2.5.1.1.1. Market size and forecast, by type
4.4.2.5.1.1.1.1. Deep Brain Stimulators (DBS)
4.4.2.5.1.1.1.1.1. Market size and forecast
4.4.2.5.1.1.1.2. Sacral Nerve Stimulators (SNS)
4.4.2.5.1.1.1.2.1. Market size and forecast
4.4.2.5.1.1.1.3. Vagus Nerve Stimulators (VNS)
4.4.2.5.1.1.1.3.1. Market size and forecast
4.4.2.5.1.1.1.4. Spinal Cord Stimulators (SCS)
4.4.2.5.1.1.1.4.1. Market size and forecast
4.4.2.5.1.1.1.5. Other Neurostimulators
4.4.2.5.1.1.1.5.1. Market size and forecast
4.4.2.5.1.2. External Neurostimulators (Transcutaneous Electrical Nerve Stimulation (TENS))
4.4.2.5.1.2.1. Market size and forecast
4.4.3. Market size and forecast, by region
4.4.4. Market analysis by country

CHAPTER 5: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER
5.1. Overview
5.2. Market size and forecast
5.3. Hospitals
5.3.1. Market size and forecast, by region
5.3.2. Market analysis by country
5.4. Ambulatory surgical centers (ASCs)
5.4.1. Market size and forecast, by region
5.4.2. Market analysis by country
5.5. Others
5.5.1. Market size and forecast, by region
5.5.2. Market analysis by country

CHAPTER 6: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY REGION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. North America vital organs support systems and medical bionics market, by country
6.2.2.1. U.S. vital organs support systems and medical bionics market, by product type
6.2.2.2. U.S. vital organs support systems and medical bionics market, by end user
6.2.2.3. Canada vital organs support systems and medical bionics market, by product type
6.2.2.4. Canada vital organs support systems and medical bionics market, by end user
6.2.2.5. Mexico vital organs support systems and medical bionics market, by product type
6.2.2.6. Mexico vital organs support systems and medical bionics market, by end user
6.2.3. North America vital organs support systems and medical bionics market, by product type
6.2.5. North America vital organs support systems and medical bionics market, by end user
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Europe vital organs support systems and medical bionics market, by country
6.3.2.1. Germany vital organs support systems and medical bionics market, by product type
6.3.2.3. Germany vital organs support systems and medical bionics market, by end user
6.3.2.4. France vital organs support systems and medical bionics market, by product type
6.3.2.6. France vital organs support systems and medical bionics market, by end user
6.3.2.7. Spain vital organs support systems and medical bionics market, by product type
6.3.2.8. Spain vital organs support systems and medical bionics market, by end user
6.3.2.9. Italy vital organs support systems and medical bionics market, by product type
6.3.2.11. Italy vital organs support systems and medical bionics market, by end user
6.3.2.12. UK vital organs support systems and medical bionics market, by product type
6.3.2.13. UK vital organs support systems and medical bionics market, by end user
6.3.2.14. Rest of Europe vital organs support systems and medical bionics market, by product type
6.3.2.15. Rest of Europe vital organs support systems and medical bionics market, by end user
6.3.3. Europe vital organs support systems and medical bionics market, by product type
6.3.5. Europe vital organs support systems and medical bionics market, by end user
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific vital organs support systems and medical bionics market, by country
6.4.2.1. Australia vital organs support systems and medical bionics market, by product type
6.4.2.2. Australia vital organs support systems and medical bionics market, by end user
6.4.2.3. Japan vital organs support systems and medical bionics market, by product type
6.4.2.4. Japan vital organs support systems and medical bionics market, by end user
6.4.2.5. India vital organs support systems and medical bionics market, by product type
6.4.2.6. India vital organs support systems and medical bionics market, by end user
6.4.2.7. China vital organs support systems and medical bionics market, by product type
6.4.2.8. China vital organs support systems and medical bionics market, by end user
6.4.2.9. South Korea vital organs support systems and medical bionics market, by product type
6.4.2.10. South Korea vital organs support systems and medical bionics market, by end user
6.4.2.11. Rest of Asia-Pacific vital organs support systems and medical bionics market, by product type
6.4.2.12. Rest of Asia-Pacific vital organs support systems and medical bionics market, by end user
6.4.3. Asia-Pacific vital organs support systems and medical bionics market, by product type
6.4.5. Asia-Pacific vital organs support systems and medical bionics market, by end user
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. LAMEA vital organs support systems and medical bionics market, by country
6.5.2.1. Brazil vital organs support systems and medical bionics market, by product type
6.5.2.2. Brazil vital organs support systems and medical bionics market, by end user
6.5.2.3. Saudi Arabia vital organs support systems and medical bionics market, by product type
6.5.2.4. Saudi Arabia vital organs support systems and medical bionics market, by end user
6.5.2.5. South Africa vital organs support systems and medical bionics market, by product type
6.5.2.6. South Africa vital organs support systems and medical bionics market, by end user
6.5.2.7. Rest of LAMEA vital organs support systems and medical bionics market, by product type
6.5.2.8. Rest of LAMEA vital organs support systems and medical bionics market, by end user
6.5.3. LAMEA vital organs support systems and medical bionics market, by product type
6.5.5. LAMEA vital organs support systems and medical bionics market, by end user

CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Market Share Analysis of Top Players, 2018 (%)
7.4. Top winning strategies
7.4.1. Top Winning Strategies, By Year, 2015-2019*
7.4.2. Top Winning Strategies, By Development, 2015-2019* (%)
7.4.3. Top Winning Strategies, By Company, 2015-2019*
7.5. Product Mapping of Top 12 Player

CHAPTER 8: COMPANY PROFILES:
8.1. Abiomed, Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Product portfolio
8.1.4. Business performance
8.1.5. Key strategic moves and developments
8.2. Abbott Laboratories (St. Jude Medical)
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.)
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. Baxter International Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. Boston Scientific Corporation
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. Cochlear Ltd.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. Edwards Lifesciences Corporation
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. Jarvik Heart, Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Key strategic moves and developments
8.9. Medtronic Plc. (Covidien Ltd.)
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. Össur Americas, Inc.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
8.11. Second Sight Medical Products, Inc.
8.11.1. Company overview
8.11.2. Company snapshot
8.11.3. Product portfolio
8.11.4. Key strategic moves and developments
8.12. SynCardia Systems LLC
8.12.1. Company overview
8.12.2. Company snapshot
8.12.3. Product portfolio

List of Tables

TABLE 01. GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017-2025 ($MILLION)
TABLE 02. VITAL ORGANS SUPPORT SYSTEMS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 03. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE FOR VITAL ORGANS SUPPORT SYSTEMS , BY REGION 2017–2025 ($MILLION)
TABLE 04. MEDICAL BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 05. EAR BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 06. ORTHOPEDIC BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 07. LOWER LIMB MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 08. ELECTRICAL BONE GROWTH STIMULATORS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 09. CARDIAC BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 10. PACEMAKER MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 11. VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 12. ARTIFICIAL HEART VALVES MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 13. NEURAL BIONICS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 14. INTERNAL NEUROSTIMULATORS MARKET REVENUE, BY TYPE, 2017–2025 ($MILLION)
TABLE 15. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE FOR MEDICAL BIONICS, BY REGION 2017–2025 ($MILLION)
TABLE 16. GLOBAL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE, BY END USER, 2017–2025 ($MILLION)
TABLE 17. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE FOR HARDWARE, BY REGION 2017–2025($MILLION)
TABLE 18. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2017–2025($MILLION)
TABLE 19. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE FOR OTHER END USERS, BY REGION, 2017–2025($MILLION)
TABLE 20. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)
TABLE 21. NORTH AMERICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 22. U.S. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 23. U.S. VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 24. CANADA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 25. CANADA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 26. MEXICO VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 27. MEXICO VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 28. NORTH AMERICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 29. NORTH AMERICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 30. EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 31. GERMANY VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 32. GERMANY VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 33. FRANCE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 34. FRANCE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 35. SPAIN VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 36. SPAIN VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 37. ITALY VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 38. ITALY VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 39. UK VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 40. UK VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 41. REST OF EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 42. REST OF EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 43. EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 44. EUROPE VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 45. ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 46. AUSTRALIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 47. AUSTRALIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 48. JAPAN VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 49. JAPAN VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 50. INDIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 51. INDIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 52. CHINA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 53. CHINA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 54. SOUTH KOREA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 55. SOUTH KOREA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 56. REST OF ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 57. REST OF ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 58. ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 59. ASIA-PACIFIC VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 60. LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 61. BRAZIL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 62. BRAZIL VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 63. SAUDI ARABIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 64. SAUDI ARABIA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 65. SOUTH AFRICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 66. SOUTH AFRICA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 67. REST OF LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 68. REST OF LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 69. LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE, 2017–2025 ($MILLION)
TABLE 70. LAMEA VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER, 2017–2025 ($MILLION)
TABLE 71. ABIOMED: COMPANY SNAPSHOT
TABLE 72. ABIOMED: PRODUCT PORTFOLIO
TABLE 73. ABBOTT: COMPANY SNAPSHOT
TABLE 74. ABBOTT: OPERATING SEGMENTS
TABLE 75. ABBOTT: PRODUCT PORTFOLIO
TABLE 76. ASAHI KASEI: COMPANY SNAPSHOT
TABLE 77. ASAHI KASEI: OPERATING SEGMENTS
TABLE 78. ASAHI KASEI: PRODUCT PORTFOLIO
TABLE 79. BAXTER: COMPANY SNAPSHOT
TABLE 80. BAXTER: OPERATING SEGMENTS
TABLE 81. BAXTER: PRODUCT PORTFOLIO
TABLE 82. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 83. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 84. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 85. COCHLEAR: COMPANY SNAPSHOT
TABLE 86. COCHLEAR: OPERATING SEGMENTS
TABLE 87. COCHLEAR: PRODUCT PORTFOLIO
TABLE 88. EDWARDS LIFESCIENCES: COMPANY SNAPSHOT
TABLE 89. EDWARDS LIFESCIENCES: PRODUCT PORTFOLIO
TABLE 90. JARVIK HEART: COMPANY SNAPSHOT
TABLE 91. JARVIK HEART: PRODUCT PORTFOLIO
TABLE 92. MEDTRONIC: COMPANY SNAPSHOT
TABLE 93. MEDTRONIC: OPERATING SEGMENTS
TABLE 94. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 95. ÖSSUR: COMPANY SNAPSHOT
TABLE 96. ÖSSUR: OPERATING SEGMENTS
TABLE 97. ÖSSUR: PRODUCT PORTFOLIO
TABLE 98. SECOND SIGHT: COMPANY SNAPSHOT
TABLE 99. SECOND SIGHT: PRODUCT PORTFOLIO
TABLE 100. SYNCARDIA: COMPANY SNAPSHOT
TABLE 101. SYNCARDIA: PRODUCT PORTFOLIO

List of Figures

FIGURE 01. KEY MARKET SEGMENTS
FIGURE 02. EXECUTIVE SUMMARY
FIGURE 03. TOP IMPACTING FACTORS
FIGURE 04. TOP INVESTMENT POCKETS
FIGURE 05. VALUE CHAIN ANALYSIS
FIGURE 06. CLINICAL TRIALS IN MEDICAL BIONICS MARKET, BY REGION
FIGURE 07. CLINICAL TRIALS FOR MEDICAL DEVICES (%)
FIGURE 08. DISTRIBUTION OF DISABLING HEARING LOSS PATIENTS (%), 2018
FIGURE 09. ARTIFICIAL HEART MARKET, 2017–2025 ($MILLION)
FIGURE 10. ARTIFICIAL KIDNEY MARKET, 2017–2025 ($MILLION)
FIGURE 11. ARTIFICIAL PANCREAS MARKET, 2017–2025 ($MILLION)
FIGURE 12. ARTIFICIAL URINARY BLADDER MARKET, 2017–2025 ($MILLION)
FIGURE 13. ARTIFICIAL LUNGS MARKET, 2017–2025 ($MILLION)
FIGURE 14. ARTIFICIAL LIVER MARKET, 2017–2025 ($MILLION)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF VITAL ORGANS SUPPORT SYSTEMS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 16. BIONIC EYE MARKET, 2017–2025 ($MILLION)
FIGURE 17. COCHLEAR IMPLANTS MARKET, 2017–2025 ($MILLION)
FIGURE 18. BONE ANCHORED HEARING SYSTEMS MARKET, 2017–2025 ($MILLION)
FIGURE 19. AUDITORY BRAINSTEM IMPLANTS MARKET, 2017–2025 ($MILLION)
FIGURE 20. UPPER LIMB MARKET, 2017–2025 ($MILLION)
FIGURE 21. BIONIC KNEE MARKET, 2017–2025 ($MILLION)
FIGURE 22. BIONIC FEET MARKET, 2017–2025 ($MILLION)
FIGURE 23. EXOSKELETON MARKET, 2017–2025 ($MILLION)
FIGURE 24. INVASIVE BONE GROWTH STIMULATORS MARKET, 2017–2025 ($MILLION)
FIGURE 25. NON-INVASIVE BONE GROWTH STIMULATORS MARKET, 2017–2025 ($MILLION)
FIGURE 26. IMPLANTABLE PACEMAKER MARKET, 2017–2025 ($MILLION)
FIGURE 27. EXTERNAL PACEMAKER MARKET, 2017–2025 ($MILLION)
FIGURE 28. LEFT VENTRICULAR ASSIST DEVICE (LVAD) MARKET, 2017–2025 ($MILLION)
FIGURE 29. RIGHT VENTRICULAR ASSIST DEVICE (RVAD) MARKET, 2017–2025 ($MILLION)
FIGURE 30. BIVENTRICULAR ASSIST DEVICE (BIVAD) MARKET, 2017–2025 ($MILLION)
FIGURE 31. MECHANICAL HEART VALVES MARKET, 2017–2025 ($MILLION)
FIGURE 32. TISSUE HEART VALVES MARKET, 2017–2025 ($MILLION)
FIGURE 33. DEEP BRAIN STIMULATORS (DBS) MARKET, 2017–2025 ($MILLION)
FIGURE 34. SACRAL NERVE STIMULATORS (SNS) MARKET, 2017–2025 ($MILLION)
FIGURE 35. VAGUS NERVE STIMULATORS (VNS) MARKET, 2017–2025 ($MILLION)
FIGURE 36. SPINAL CORD STIMULATORS (SCS) MARKET, 2017–2025 ($MILLION)
FIGURE 37. OTHER NEUROSTIMULATORS MARKET, 2017–2025 ($MILLION)
FIGURE 38. EXTERNAL NEUROMODULATORS MARKET, 2017–2025 ($MILLION)
FIGURE 39. COMPARATIVE SHARE ANALYSIS OF MEDICAL BIONICS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 40. COMPARATIVE SHARE ANALYSIS OF NON-COATED VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 41. COMPARATIVE SHARE ANALYSIS OF VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2017 & 2025 (%)
FIGURE 42. COMPARATIVE SHARE ANALYSIS OF VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET FOR OTHER END USERS, BY COUNTRY, 2017 & 2025 (%)
FIGURE 43. MARKET SHARE ANALYSIS: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, 2018 (%)
FIGURE 44. PRODUCT MAPPING OF TOP 12 PLAYERS
FIGURE 45. ABIOMED: NET SALES, 2015–2017 ($MILLION)
FIGURE 46. ABBOTT: NET SALES, 2016–2018 ($MILLION)
FIGURE 47. ABBOTT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 48. ABBOTT: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 49. ASAHI KASEI: NET SALES, 2015–2017 ($MILLION)
FIGURE 50. ASAHI KASEI: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 51. ASAHI KASEI: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 52. BAXTER: NET SALES, 2015–2017 ($MILLION)
FIGURE 53. BAXTER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 54. BAXTER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 55. BOSTON SCIENTIFIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 56. BOSTON SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 57. BOSTON SCIENTIFIC: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 58. COCHLEAR: NET SALES, 2016–2018 ($MILLION)
FIGURE 59. COCHLEAR: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 60. COCHLEAR: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 61. EDWARDS LIFESCIENCES: NET SALES, 2015–2017 ($MILLION)
FIGURE 62. EDWARDS LIFESCIENCES: REVENUE SHARE BY PRODUCT, 2017 (%)
FIGURE 63. EDWARDS LIFESCIENCES: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 64. MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 65. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 66. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 67. ÖSSUR: NET SALES, 2016–2018 ($MILLION)
FIGURE 68. ÖSSUR: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 69. ÖSSUR: REVENUE SHARE BY GEOGRAPHY, 2018 (%)